• Investing Ideas
  • /
  • Global Pharmaceuticals & Biotech Dollar's Gain Retailers' Pain
721 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

300404

Boji Medical TechnologyLtd
CN¥8.074.4%-14.0%CN¥3.1bn/aPE105.1xE64.4%0.1%

RGEN

Repligen
US$167.722.1%6.2%US$9.4bUS$204.16PE631.4xE60.5%n/a

GILD

Gilead Sciences
US$65.460.4%-16.9%US$81.7bUS$82.93PE168.3xE36.5%4.7%

2603

Shijiazhuang Yiling Pharmaceutical
CN¥19.483.5%-32.4%CN¥32.5bCN¥20.09PE71.7xE45.8%1.5%

ALIF B

AddLife
kr102.900.3%-16.0%kr12.5bkr137.00PE160.8xE54.5%0.5%

A086900

Medy-Tox
₩138,000.002.2%-43.9%₩928.8b₩296,000.00PE105.8xE75.6%0.8%

300639

Guangdong Hybribio BiotechLtd
CN¥6.585.1%-29.7%CN¥4.2bn/aPE69.5xE71.2%1.0%

603520

Zhejiang Starry PharmaceuticalLtd
CN¥12.872.4%-23.4%CN¥4.4bCN¥17.54PE93.9xE64.5%3.9%

SUPN

Supernus Pharmaceuticals
US$30.42-0.6%-17.3%US$1.7bUS$40.33PE1270.7xE58.3%n/a

4746

Formosa Laboratories
NT$97.20-3.8%9.0%NT$11.7bNT$137.50PE92.6xS13.9%2.1%

BTMD

biote
US$6.0610.6%-12.2%US$383.0mUS$8.65PE63.3xE49.3%n/a

301230

PharmaResources (Shanghai)
CN¥36.043.2%-10.4%CN¥3.9bn/aPE149.1xE76.8%0.9%

4503

Astellas Pharma
JP¥1,562.503.2%-25.9%JP¥2.8tJP¥2,025.00PE164.4xE29.8%4.7%

PHM

Pharma Mar
€31.603.8%-12.2%€557.4m€49.20PE490.3xE43.8%2.1%

GRF

Grifols
€9.5210.1%-8.6%€5.7b€17.27PE109xE28.8%n/a

MRK

Merck
US$130.380.9%11.0%US$323.1bUS$141.64PE143.2xE24.9%2.4%

TLX

Telix Pharmaceuticals
AU$14.97-0.5%41.2%AU$4.9bAU$15.29PE949.3xE36.2%n/a

SDZ

Sandoz Group
CHF31.00-0.5%n/aCHF13.3bCHF34.99PE190.7xE29.6%1.4%

603392

Beijing Wantai Biological Pharmacy Enterprise
CN¥70.232.9%1.0%CN¥89.1bCN¥70.40PE693.3xE63.0%0.5%

SRPT

Sarepta Therapeutics
US$136.047.4%8.5%US$12.8bUS$165.89PE761xE37.0%n/a

A096530

Seegene
₩22,150.000%-9.6%₩1.0t₩25,000.00PE1524.5xE108.1%3.6%

ABCM

Abcam
US$23.990.08%54.7%US$5.5bUS$23.66PE1758.5xE39.3%0%

VTRS

Viatris
US$11.721.3%20.3%US$14.0bUS$12.46PE254.4xE16.8%4.1%

INDV

Indivior
UK£14.35-0.5%-6.1%UK£1.9bUK£24.41PE487.2xE34.7%0%
Page 30 of 31
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.